MedTrace Logo

Alcohol and Other Psychoactive Substances in Road Traffic - a Case-control Study

NCT00570518 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2011-10-03

No results posted yet for this study

Summary

The main purpose of the study is to determine the accident risk when driving under the influence of psychoactive substances, including alcohol (DUI). Other aims are to find out the prevalence of psychoactive substances in road traffic and to obtain information on the role of these substances in road traffic accident causations.

For the purposes of the study, drivers of motorised vehicles are randomly stopped and interviewed and breath alcohol is recorded. Also, an oral fluid sample is taken and psychoactive substances are investigated in the laboratory. For cases, drivers injured in traffic accidents are asked to participate to the study. A whole blood sample and, if possible, an oral fluid sample is taken and psychoactive substances are determined in the laboratory. Also, people diseased in road traffic accident are included in the study. The information required for these subjects are taken from a register database.

The study is part of an EU-project DRUID. Altogether 13 European countries take part to the study.

Conditions

  • Prevalence of Psychoactive Substances in Road Traffic
  • Psychoactive Substances in Accident Involved Drivers
  • Relative Risk Estimation of Accident Involvement for Impaired Drivers

Sponsors & Collaborators

  • Hospital District of Helsinki and Uusimaa

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Pirjo Lillsunde, Dr · National Public Health Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Completion
2011-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570518 on ClinicalTrials.gov